Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

4.73
Delayed Data
As of Mar 22
 -0.219 / -4.43%
Today’s Change
4.62
Today|||52-Week Range
50.70
-51.49%
Year-to-Date
No recent news for Catalyst Biosciences Inc.

Today’s Trading

Previous close4.95
Today’s open4.80
Day’s range4.62 - 4.92
Volume29,317
Average volume (3 months)58,993
Market cap$4.9M
Dividend yield12.04%
Data as of 3:59pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+56.46%
Earnings growth (this year)+28.51%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)-77.20%
P/E ratioNM
Price/Sales19.04
Price/Book0.25

Competitors

 Today’s
change
Today’s
% change
OPXAOpexa Therapeutics I...-0.02-2.27%
BSPMBiostar Pharmaceutic...-0.13-5.53%
SSKNSTRATA Skin Sciences...+0.02+3.18%
--VANC Pharmaceuticals...-0.07-23.21%
Data as of 3:59pm ET, 03/22/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)-$6.15
Annual revenue (last year)$399.0K
Annual profit (last year)-$16.9M
Net profit margin-4,246.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
Chief Financial Officer &
Head-Investor Relations
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs